Given its pivotal role in actin dynamics and disease states, cofilin is being explored as a potential therapeutic target. Strategies to modulate cofilin activity could involve the development of small molecules that either inhibit or enhance its activity. Additionally, targeting the upstream signaling pathways that regulate cofilin phosphorylation could provide therapeutic benefits.
